L-tyrosine is the rate-limiting amino acid precursor for dopamine and norepinephrine. Because the enzyme tyrosine hydroxylase is already ~75% saturated at rest, supplemental L-tyrosine shows little or no cognitive effect at unstressed baseline. Its benefit appears selectively during acute catecholamine-depleting stress: preventing an 18% working-memory drop in cold exposure, preserving vigilance after 40 hours of sleep deprivation, and supporting complex multitasking in short-term crossover trials (very low GRADE certainty due to small sample sizes and zero long-term outcome trials). Across human studies, L-tyrosine is blood-pressure neutral or mildly lowers blood pressure under stress (Sole 1985; Deijen 1999). Take it on an empty stomach to avoid LAT1 transporter competition with dietary amino acids, and avoid it with MAO inhibitors (tyramine pressor pathway) or around levodopa dosing (54% to 75% striatal uptake block).
TL;DR: L-tyrosine is the amino acid building block your brain uses to make dopamine and norepinephrine. Clinical trials tell a clear story about when it works and when it does nothing:
- The Stress-Specificity Rule (Jongkees 2015; Hase 2015): The rate-limiting enzyme tyrosine hydroxylase is already ~75% saturated at rest. Taking L-tyrosine on a calm, well-rested day does almost nothing. It works selectively when acute stress, sleep loss, or cold exposure drains dopamine and norepinephrine faster than diet can refill them.
- What human crossover trials show (Very low GRADE certainty, Crawford 2021): Short-term crossover trials (n = 8 to 76; no long-term human outcome trials exist) tested 2 g or 100 to 150 mg/kg of L-tyrosine. It prevented an 18% memory drop and 14% marksmanship drop in cold immersion (O'Brien 2007), kept vigilance steady across 40 hours of sleep loss (Magill 2003), and improved 2-back multitasking (Thomas 1999; Colzato 2014). By contrast, it showed zero benefit in 40°C heat (Coull 2016) and worsened mental flexibility in unstressed high-dopamine adults (Robson 2020).
- Blood-pressure neutral in human trials (Sole 1985; Deijen 1999): Oral L-tyrosine does not raise blood pressure in non-MAOI users. Human trials show neutral or slightly lower blood pressure under stress (Deijen 1994 & 1999) and zero blood pressure change at 7.5 g/day in mild hypertension (Sole et al., Hypertension 1985).
- Key interactions (MAOIs, Levodopa, and ATA thyroid warnings): Never combine L-tyrosine with MAO inhibitors (tyramine pressor risk, AHA 2018). Separate it from levodopa in Parkinson's disease, where LAT1 transporter competition cuts striatal levodopa uptake by 54% to 75% (Rusch 2023). Take 500 to 2,000 mg on an empty stomach only on high-demand days.
In our Philadelphia practice, many patients walk in convinced they have developed adult-onset ADHD. Some truly have lifelong adult ADHD. Many others have an acute supply-side depletion problem. After nights of broken sleep, shift work, or heavy cognitive load, their brain burns through dopamine and norepinephrine faster than dietary protein can replace them. Prescription stimulants force the release of catecholamines already stored in the nerve terminal. L-tyrosine works upstream on the supply side, refilling the precursor pool when acute stress has drained the tank.
How does L-tyrosine work, and why does it only help under stress?
L-tyrosine is the rate-limiting amino acid building block for dopamine and norepinephrine. The enzyme tyrosine hydroxylase is already ~75% saturated at rest, so extra L-tyrosine only boosts synthesis when acute stress drains the local pool (Jongkees et al., J Psychiatr Res 2015; Hase et al., 2015).123
The pathway inside catecholamine neurons runs in three steps:
- L-Tyrosine $\to$ L-DOPA via the rate-limiting enzyme tyrosine hydroxylase (requiring tetrahydrobiopterin [BH4] and iron).
- L-DOPA $\to$ Dopamine via aromatic L-amino acid decarboxylase (requiring active vitamin B6 as pyridoxal-5'-phosphate [P-5-P]).
- Dopamine $\to$ Norepinephrine via dopamine beta-hydroxylase (requiring vitamin C and copper).14
On a calm, well-rested day, tyrosine hydroxylase is roughly 75% saturated with tyrosine. Taking extra L-tyrosine at rest cannot push dopamine synthesis higher.12 When you face sleep loss, cold exposure, or intense multitasking, catecholamine neurons fire rapidly. The enzyme needs more fuel, and oral L-tyrosine refills the drained vesicles to protect working memory.234
What do human clinical trials show (Acute Stress vs. Unstressed Baseline)?
Across randomized crossover trials, acute oral L-tyrosine (100 to 150 mg/kg or 2,000 mg) buffers memory and vigilance drops during sleep loss, cold stress, and multitasking. It shows zero benefit at rest and can reduce mental flexibility when baseline dopamine is high (very low GRADE certainty overall, with zero long-term trials).2356
| Stressor / Condition | Trial Design & Sample (n) | Oral L-Tyrosine Dose | Cognitive & Physiological Outcome vs. Placebo | Key Nuance & Evidence Certainty |
|---|---|---|---|---|
| Cold Air Exposure (Shurtleff et al., Pharmacol Biochem Behav 1994) | Double-blind crossover (n = 8) | 150 mg/kg | Reversed cold-induced (4°C) working-memory (DMTS) drop; zero effect at 22°C room temperature.7 | Proves stress specificity: helps at 4°C, does nothing at rest.7 |
| Cold-Water Immersion (Mahoney et al., 2007; O'Brien et al., Physiol Behav 2007) | Randomized crossover (n = 15 to 19) | 150 to 300 mg/kg | Cold + placebo cut memory accuracy by 18% and marksmanship by 14%; L-tyrosine (300 mg/kg) prevented both drops.89 | Replicated across two cold-immersion protocols.89 |
| Sleep Deprivation (~40 Hours Awake, Magill et al., Nutr Neurosci 2003; Waters et al., 2003) | Parallel RCT (n = 76) vs placebo, caffeine, phentermine, & d-amphetamine | 150 mg/kg | Improved working memory, reasoning, vigilance, and tracking vs placebo after a sleepless night, without disrupting recovery sleep.1011 | Largest sleep-loss trial; active effect lasted ~3 to 4 hours.1011 |
| Cold + High-Altitude Hypoxia (Banderet & Lieberman, Brain Res Bull 1989) | Double-blind crossover (n = 23) | 100 mg/kg | Cut headache, coldness, distress, and fatigue while preserving reaction time and vigilance across 4.5 hours of hypoxia + cold.12 | Classic military stress study.12 |
| 6-Day Military Combat Course (Deijen et al., Brain Res Bull 1999) | Controlled parallel trial (n = 21 cadets) | 2,000 mg/day (2 g/day for 6 days) | Improved memory and tracking scores AND lowered systolic blood pressure compared with placebo.13 | Shows benefit at a practical 2 g/day dose.13 |
| Complex Multitasking & N-Back Load (Thomas et al., 1999; Colzato et al., 2014) | Double-blind crossover (n = 20 to 22) | 150 mg/kg or 2,000 mg | Improved working memory on high-load multitasking and the hard 2-back task, with zero effect on easy 1-back tasks.1415 | Heavy mental load acts as an internal stressor.1415 |
| Exercise in 40°C Heat (Coull et al., Med Sci Sports Exerc 2016) | Double-blind crossover (n = 8) | 150 mg/kg | No gain in vigilance or physical time-trial performance in 40°C heat despite a 2.5x rise in blood tyrosine.16 | Important null trial: heat fatigue is not fixed by tyrosine.16 |
| Unstressed High Load & DRD2 Genotype (Robson et al., J Affect Disord 2020; Jongkees 2020; Colzato 2016) | Parallel RCT (n = 70, Robson) & genotype RCTs | 2,000 mg (2 g) | 2 g worsened mental flexibility (Wisconsin Card Sorting) in unstressed young adults (Robson 2020); effect depends on DRD2 C957T genotype.171819 | Shows the dopamine inverted-U curve: excess precursor in a rested brain can cause mental rigidity.171819 |
Evidence certainty & limits (Crawford et al., 2021; Attipoe et al., 2015): Reviews rate the overall certainty of evidence as very low by GRADE.56 Trials are small (n = 8 to 76) and last from one dose up to 6 days. Many use weight-based doses (100 to 150 mg/kg, or 7 to 10 g in a 70 kg adult), and no long-term human outcome trials exist.356
Does L-tyrosine raise blood pressure?
No. Even though L-tyrosine is a norepinephrine building block, human clinical trials show a neutral or mildly blood-pressure-lowering effect under stress (Sole et al., Hypertension 1985; Deijen et al., 1994 & 1999).132021
When L-tyrosine refills norepinephrine neurons in the brainstem (nucleus tractus solitarii and locus coeruleus), those neurons stimulate central alpha-2 receptors that turn down peripheral nerve traffic:
- Acute stress trials (Deijen & Orlebeke, 1994; Deijen et al., 1999; Dollins et al., 1995; Lang & Smaller, Exp Physiol 2017): Under 90 dB noise stress (100 mg/kg) and during a 6-day combat course (2 g/day), L-tyrosine lowered diastolic and systolic blood pressure compared with placebo.1320 During whole-body cooling in older adults (150 mg/kg), L-tyrosine supported skin blood-vessel tone without changing blood pressure or heart rate.2223
- Essential hypertension trial (Sole et al., Hypertension 1985): Adults with mild high blood pressure took 7.5 g/day of L-tyrosine for 2 weeks in a controlled trial. They had zero change in blood pressure, heart rate, or blood norepinephrine.21242526
- The one exception: Blood pressure can jump dangerously if L-tyrosine is combined with MAO inhibitors (covered below).
Who should avoid L-tyrosine (MAOIs, Levodopa, and the Thyroid Adulteration Trap)?
Before trying L-tyrosine, we check three clinical interactions (Gate 2 in how we choose supplements):
1. MAO Inhibitors (Hard Contraindication via Tyramine)
Irreversible or non-selective monoamine oxidase inhibitors (MAOIs: phenelzine, tranylcypromine, isocarboxazid, selegiline, or linezolid) block the breakdown of monoamines and tyramine (Gillman, J Neural Transm 2018; Van den Eynde, 2021).2728 Tyramine is the trace amine in aged cheese that causes hypertensive crisis (SBP > 180 or DBP > 120 mmHg). A small fraction of oral L-tyrosine can convert into tyramine in the gut or tissues. The American Heart Association (AHA 2018 Resistant Hypertension Statement, Carey et al.) notes that MAOI blood pressure surges are magnified when amine precursors are co-ingested.282930 Never combine L-tyrosine with an MAOI.
Fishtown Medicine
A 90-minute conversation with Dr. Ash. A written plan you can follow.
2. Levodopa in Parkinson's Disease (54% to 75% Striatal Uptake Block via LAT1)
L-tyrosine is a large neutral amino acid (LNAA). It shares the same gut (b0,+AT/LAT2) and blood-brain barrier (LAT1) transporters as levodopa (Camargo et al., JPET 2014; Rusch et al., NPJ Parkinsons Dis 2023; Müller 2024; Riederer 2025).31323334 In primate and human studies, taking LNAAs with levodopa cuts striatal levodopa uptake by 54% to 75%.323335 That competition can cause sudden motor "off" episodes even when blood levodopa levels look normal. Patients on levodopa should avoid L-tyrosine or separate it from medication windows under neurologist care. (This same LAT1 competition is why everyone else should take L-tyrosine on an empty stomach away from protein meals.)
3. Thyroid Disease (AACE/ATA 2012 & ATA 2014 Guidance vs. Spiked Supplements)
The thyroid gland links iodine to tyrosine on thyroglobulin to build T4 and T3. Even so, free tyrosine is not rate-limiting for thyroid hormone output.3637 Both the AACE/ATA 2012 (Garber et al.) and ATA 2014 (Jonklaas et al.) guidelines state that no clinical evidence shows L-tyrosine raises thyroid hormone levels.3839 Both guidelines advise against using tyrosine for hypothyroidism.
- Why we screen thyroid status & warn against "Thyroid Support" blends (Kang et al., Thyroid 2013): First, in active hyperthyroidism or Graves' disease, extra catecholamine fuel can worsen rapid heart rate or tremors (Tranylcypromine FDA Label 2025).30 Second, Kang et al. (Thyroid 2013) tested 10 over-the-counter "thyroid health" supplements sold with L-tyrosine and herbs. 9 out of 10 products contained hidden prescription-strength T4 (thyroxine) and T3 (liothyronine) from animal thyroid tissue.3940 Those hidden hormones can cause dangerous hyperthyroidism and atrial fibrillation. Always buy single-ingredient, third-party-tested (USP, NSF, or ConsumerLab) free-form L-tyrosine.
How to dose L-tyrosine (and why we pulse-dose)
We use L-tyrosine as a targeted pulse tool on high-demand days, not as a daily habit:
- Form: Free-form L-tyrosine raises blood and brain tyrosine levels far better than N-acetyl L-tyrosine (NALT). Humans poorly break down NALT and pass most of it in urine.
- Clinical pulse dose: Take 500 to 2,000 mg (0.5 to 2 g) about 30 to 60 minutes before a hard mental block or after a short night of sleep. (Military trials use 100 to 150 mg/kg [7 to 10 g], which beats 2 g during 40-hour sleep loss or cold immersion. Doses above 2 g can cause mild stomach upset or mental rigidity in office settings.)51013
- Empty stomach (LAT1 rule): Take it with water or black coffee 30 to 45 minutes before breakfast or 2 hours after a protein meal. That keeps food amino acids from blocking L-tyrosine at the LAT1 carrier.3132
- Cofactors: Keep vitamin B6 (P-5-P), folate, vitamin C, iron, and copper replete. Those cofactors help convert L-tyrosine into dopamine and norepinephrine.
Guidance from the Clinic
Actionable Steps
Use L-tyrosine as a pulse tool on acute high-demand days:
- Check the Interaction Gate First: Do not take L-tyrosine if you use MAO inhibitors, take levodopa for Parkinson's disease (54% to 75% uptake block), or have untreated hyperthyroidism / Graves' disease.
- Choose Pure Free-Form L-Tyrosine (Never "Thyroid Blends"): Pick a single-ingredient free-form L-tyrosine verified by USP, NSF, or ConsumerLab. Avoid NALT and commercial "thyroid support" blends (9 of 10 tested in Kang 2013 contained hidden T4/T3).
- Take 500 to 2,000 mg on an Empty Stomach: Take it with water or black coffee 30 to 60 minutes before your demanding work block, well away from protein meals so L-tyrosine crosses the LAT1 transporter without competition.
- Save It for Acute Sleep Loss or Heavy Multitasking (Pulse Dosing): Skip it on calm, well-rested days, where baseline dopamine is already optimal and extra precursor can reduce mental flexibility (inverted-U curve).
- Fix the Upstream Drain: If you need L-tyrosine every morning just to function, start an intake with Dr. Ash so we can check sleep architecture, ferritin, thyroid function, or adult ADHD.
Key Takeaways
- L-tyrosine refills catecholamine stores (L-tyrosine -> L-DOPA -> dopamine -> norepinephrine) selectively during acute stress. The enzyme tyrosine hydroxylase is already ~75% saturated at rest (Jongkees 2015; Hase 2015).23
- Short-term crossover trials (very low GRADE certainty, zero long-term trials) show working-memory protection during cold exposure (prevented 18% memory & 14% marksmanship drop), 40-hour sleep loss (Magill 2003), and complex multitasking (2-back). It shows no benefit in 40°C heat (Coull 2016) and lower flexibility at unstressed baseline (Robson 2020).59101617
- Human trials show L-tyrosine is blood-pressure neutral or mildly lowers blood pressure under stress (Sole 1985; Deijen 1999), except when combined with MAO inhibitors.1321
- Take 500 to 2,000 mg of third-party-tested free-form L-tyrosine on an empty stomach (LAT1 transporter rule) only on high-demand days. Avoid it with MAO inhibitors (tyramine pressor risk) or around levodopa (54% to 75% uptake block).2832
A note on cost: any discount we negotiate on professional-grade supplements passes straight through to you, with no markup. Read how Fishtown Medicine chooses and sources supplements.
Scientific References
- Ahrens S, Laux J, Müller C, Thiel CM. "Increased dopamine availability magnifies nicotine effects on cognitive control: A pilot study." Journal of Psychopharmacology. 2020;34(4):434-442. DOI
- Jongkees BJ, Hommel B, Kühn S, Colzato LS. "Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands - a review." Journal of Psychiatric Research. 2015;70:50-57. PubMed
- Hase A, Jung SE, aan het Rot M. "Behavioral and cognitive effects of tyrosine intake in healthy human adults." Pharmacology, Biochemistry, and Behavior. 2015;133:1-6. PubMed
- Meeusen R. "Exercise, Nutrition and the Brain." Sports Medicine. 2014;44(Suppl 1):S47-S56. DOI
- Crawford C, Boyd C, Deuster PA. "Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review." The Journal of Alternative and Complementary Medicine. 2021;27(11):940-958. DOI
- Attipoe S, Zeno SA, Lee C, et al. "Tyrosine for Mitigating Stress and Enhancing Performance in Healthy Adult Humans, a Rapid Evidence Assessment of the Literature." Military Medicine. 2015;180(7):754-765. PubMed
- Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harford R. "Tyrosine reverses a cold-induced working memory deficit in humans." Pharmacology, Biochemistry, and Behavior. 1994;47(4):935-941. PubMed
- Mahoney CR, Castellani J, Kramer FM, Young A, Lieberman HR. "Tyrosine supplementation mitigates working memory decrements during cold exposure." Physiology & Behavior. 2007;92(4):575-582. PubMed
- O'Brien C, Mahoney C, Tharion WJ, Sils IV, Castellani JW. "Dietary tyrosine benefits cognitive and psychomotor performance during body cooling." Physiology & Behavior. 2007;90(2-3):301-307. PubMed
- Magill RA, Waters WF, Bray GA, et al. "Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation." Nutritional Neuroscience. 2003;6(4):237-246. PubMed
- Waters WF, Magill RA, Bray GA, et al. "A comparison of tyrosine against placebo, phentermine, caffeine, and D-amphetamine during sleep deprivation." Nutritional Neuroscience. 2003;6(4):221-235. PubMed
- Banderet LE, Lieberman HR. "Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans." Brain Research Bulletin. 1989;22(4):759-762. PubMed
- Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ. "Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course." Brain Research Bulletin. 1999;48(2):203-209. PubMed
- Thomas JR, Lockwood PA, Singh A, Deuster PA. "Tyrosine improves working memory in a multitasking environment." Pharmacology, Biochemistry, and Behavior. 1999;64(3):495-500. PubMed
- Colzato LS, Jongkees BJ, Sellaro R, Hommel B. "Working memory reloaded: tyrosine repletes updating in the N-back task." Frontiers in Behavioral Neuroscience. 2013;7:200. PubMed
- Coull N, Chrismas B, Watson P, Horsfall R, Taylor L. "Tyrosine Ingestion and Its Effects on Cognitive and Physical Performance in the Heat." Medicine & Science in Sports & Exercise. 2016;48(2):277-286. PubMed
- Robson A, Lim LW, Aquili L. "Tyrosine negatively affects flexible-like behaviour under cognitively demanding conditions." Journal of Affective Disorders. 2020;260:329-333. PubMed
- Jongkees BJ. "Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating." Cognitive, Affective, & Behavioral Neuroscience. 2020;20(3):521-535. PubMed
- Colzato LS, Steenbergen L, Sellaro R, Stock AK, Arning L, Beste C. "Effects of l-Tyrosine on working memory and inhibitory control are determined by DRD2 genotypes: A randomized controlled trial." Cortex. 2016;82:217-224. PubMed
- Deijen JB, Orlebeke JF. "Effect of tyrosine on cognitive function and blood pressure under stress." Brain Research Bulletin. 1994;33(3):319-323. PubMed
- Sole MJ, Benedict CR, Myers MG, Leenen FH, Anderson GH. "Chronic dietary tyrosine supplements do not affect mild essential hypertension." Hypertension. 1985;7(4):593-596. PubMed
- Lang JA, Smaller KA. "Oral L-tyrosine supplementation augments the vasoconstriction response to whole-body cooling in older adults." Experimental Physiology. 2017;102(7):835-844. PubMed
- Dollins AB, Krock LP, Storm WF, Wurtman RJ, Lieberman HR. "L-tyrosine ameliorates some effects of lower body negative pressure stress." Physiology & Behavior. 1995;57(2):223-230. PubMed
- Agharanya JC, Alonso R, Wurtman RJ. "Changes in catecholamine excretion after short-term tyrosine ingestion in normally fed human subjects." The American Journal of Clinical Nutrition. 1981;34(1):82-87. PubMed
- Rasmussen DD, Ishizuka B, Quigley ME, Yen SS. "Effects of tyrosine and tryptophan ingestion on plasma catecholamine and 3,4-dihydroxyphenylacetic acid concentrations." The Journal of Clinical Endocrinology & Metabolism. 1983;57(4):760-763. PubMed
- Benedict CR, Anderson GH, Sole MJ. "The influence of oral tyrosine and tryptophan feeding on plasma catecholamines in man." The American Journal of Clinical Nutrition. 1983;38(3):429-435. PubMed
- Van den Eynde V. "The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors." Journal of Neural Transmission. 2021;128(11):1741-1756. DOI
- Gillman PK. "A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths." Journal of Neural Transmission. 2018;125(11):1707-1717. DOI
- Carey RM, Calhoun DA, Bakris GL, et al. "Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association." Hypertension. 2018;72(5):e53-e90. PMC
- Food and Drug Administration. "Tranylcypromine Sulfate Prescribing Information." Updated 2025. DailyMed
- Camargo SM, Vuille-dit-Bille RN, Mariotta L, et al. "The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease." The Journal of Pharmacology and Experimental Therapeutics. 2014;351(1):114-123. PubMed
- Rusch C, Flanagan R, Suh H, Subramanian I. "To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease." NPJ Parkinson's Disease. 2023;9(1):98. DOI
- Müller T, Gerlach M, Hefner G, et al. "Therapeutic drug monitoring in Parkinson's disease." Journal of Neural Transmission. 2024;131(10):1247-1262. DOI
- Riederer P, Strobel S, Nagatsu T, et al. "Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression." Journal of Neural Transmission. 2025. DOI
- Olanow CW, Stern MB, Sethi K. "The scientific and clinical basis for the treatment of Parkinson disease (2009)." Neurology. 2009;72(21 Suppl 4):S1-S136. PubMed
- Slominski A, Zmijewski MA, Pawelek J. "L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions." Pigment Cell & Melanoma Research. 2012;25(1):14-27. DOI
- de Oliveira J, Farias HR, Streck EL. "Experimental evidence of tyrosine neurotoxicity: focus on mitochondrial dysfunction." Metabolic Brain Disease. 2021;36(7):1673-1685. DOI
- Garber JR, Cobin RH, Gharib H, et al. "Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association." Thyroid. 2012;22(12):1200-1235. DOI
- Jonklaas J, Bianco AC, Bauer AJ, et al. "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement." Thyroid. 2014;24(12):1670-1751. DOI
- Kang GY, Parks JR, Fileta B, et al. "Thyroxine and Triiodothyronine Content in Commercially Available Thyroid Health Supplements." Thyroid. 2013;23(10):1233-1237. DOI
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
The chat is our AI assistant, answering from our published guides. To talk it through with Dr. Ash himself, start with the intake.





